| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.58 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.25 | 3e-05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.22 | 8e-05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.001 |